These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 11457879

  • 1. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
    Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H.
    J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
    [Abstract] [Full Text] [Related]

  • 2. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
    Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, Hashimoto N, Asano M, Takasawa S, Okamoto H, Yamamoto H.
    Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
    [Abstract] [Full Text] [Related]

  • 3. Receptor for advanced glycation end products is a promising target of diabetic nephropathy.
    Yamamoto Y, Doi T, Kato I, Shinohara H, Sakurai S, Yonekura H, Watanabe T, Myint KM, Harashima A, Takeuchi M, Takasawa S, Okamoto H, Hashimoto N, Asano M, Yamamoto H.
    Ann N Y Acad Sci; 2005 Jun; 1043():562-6. PubMed ID: 16037279
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [Abstract] [Full Text] [Related]

  • 6. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y, Lin S, Zhou J.
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [Abstract] [Full Text] [Related]

  • 8. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y.
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The RAGE axis in early diabetic retinopathy.
    Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL, Buciarelli LG, Wendt T, Hörig H, Hudson BI, Qu W, Weinberg AD, Yan SF, Schmidt AM.
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2916-24. PubMed ID: 16043866
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells.
    Tsuji H, Iehara N, Masegi T, Imura M, Ohkawa J, Arai H, Ishii K, Kita T, Doi T.
    Biochem Biophys Res Commun; 1998 Apr 17; 245(2):583-8. PubMed ID: 9571198
    [Abstract] [Full Text] [Related]

  • 13. Expression of receptors for advanced glycosylated end-products in renal disease.
    Abel M, Ritthaler U, Zhang Y, Deng Y, Schmidt AM, Greten J, Sernau T, Wahl P, Andrassy K, Ritz E.
    Nephrol Dial Transplant; 1995 Apr 17; 10(9):1662-7. PubMed ID: 8559486
    [Abstract] [Full Text] [Related]

  • 14. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
    Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H.
    Diabetes; 2007 Feb 17; 56(2):363-72. PubMed ID: 17259380
    [Abstract] [Full Text] [Related]

  • 15. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
    Jensen LJ, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A.
    J Endocrinol; 2006 Mar 17; 188(3):493-501. PubMed ID: 16522729
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.
    Inagi R, Nangaku M, Miyata T.
    Ann N Y Acad Sci; 2005 Jun 17; 1043():605-8. PubMed ID: 16037283
    [Abstract] [Full Text] [Related]

  • 20. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
    Harashima A, Yamamoto Y, Cheng C, Tsuneyama K, Myint KM, Takeuchi A, Yoshimura K, Li H, Watanabe T, Takasawa S, Okamoto H, Yonekura H, Yamamoto H.
    Biochem J; 2006 May 15; 396(1):109-15. PubMed ID: 16503878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.